Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Janssen

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Antiviral Research|April 1, 1994
Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapyH L Janssen, C J Kerhof-Los, R A Heijtink, et al.
Journal of Hepatology|August 1, 1994
Suicide associated with alfa-interferon therapy for chronic viral hepatitisH L Janssen, J T Brouwer, R C van der Mast, et al.
Journal of Medical Virology|February 15, 2001
Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replicationR A Heijtink, H L Janssen, W C Hop, et al.
Journal of Medical Virology|August 1, 1993
Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assaysH L Janssen, Y A Schoenmaker-Weber, H Kruining, et al.
Journal of Hepatology|January 1, 1993
Repeated courses of alpha-interferon for treatment of chronic hepatitis type BH L Janssen, S W Schalm, L Berk, et al.
Hepatology (Baltimore, Md.)|March 1, 1993
Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trialH L Janssen, L Berk, R A Heijtink, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 25, 1992
[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B]H L Janssen, L Berk, R A de Man, et al.
Journal of Viral Hepatitis|September 6, 2000
Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapyR A Heijtink, H L Janssen, W C Hop, et al.
BMJ (Clinical Research Ed.)|January 9, 1993
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)H L Janssen, J T Brouwer, F Nevens, et al.
Antiviral Research|October 24, 2001
Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?A B van Nunen, H L Janssen, L M Wolters, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Antiviral Research|April 1, 1994
Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapyH L Janssen, C J Kerhof-Los, R A Heijtink, et al.
Journal of Hepatology|August 1, 1994
Suicide associated with alfa-interferon therapy for chronic viral hepatitisH L Janssen, J T Brouwer, R C van der Mast, et al.
Journal of Medical Virology|February 15, 2001
Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replicationR A Heijtink, H L Janssen, W C Hop, et al.
Journal of Medical Virology|August 1, 1993
Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assaysH L Janssen, Y A Schoenmaker-Weber, H Kruining, et al.
Journal of Hepatology|January 1, 1993
Repeated courses of alpha-interferon for treatment of chronic hepatitis type BH L Janssen, S W Schalm, L Berk, et al.
Hepatology (Baltimore, Md.)|March 1, 1993
Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trialH L Janssen, L Berk, R A Heijtink, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 25, 1992
[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B]H L Janssen, L Berk, R A de Man, et al.
Journal of Viral Hepatitis|September 6, 2000
Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapyR A Heijtink, H L Janssen, W C Hop, et al.
BMJ (Clinical Research Ed.)|January 9, 1993
Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)H L Janssen, J T Brouwer, F Nevens, et al.
Antiviral Research|October 24, 2001
Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?A B van Nunen, H L Janssen, L M Wolters, et al.
Pageof 4